Hyperoxaluria - 26 Studies Found

Active, not recruiting : Proteomics of Primary Hyperoxaluria Type 1
: Primary Hyperoxaluria Type 1
: 2017-02-09
: Other: Observational Not an interventional study. Analyses of previously collected urine specimens and d
Completed : Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1
: Primary Hyperoxaluria Type 1 (PH1)
: 2016-03-03
:
  • Drug: ALN-GO1 Single or multip
Completed : Oxazyme in Patients With Hyperoxaluria
: Hyperoxaluria
: 2010-05-14
: Drug: Oxazyme Oxazyme (registered trademark) is a non-syst
Completed : Phase 2/3 Oxabact Study
: Primary Hyperoxaluria
: 2009-12-18
:
  • Biological: Oxalobacter formigenes

Active, not recruiting : Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
:
  • Enteric Hyperoxaluria
  • Hyperoxaluria : 2007-12-26
    : Drug: C-13 labeled oxalate A single prescribed dose of C-1
Completed : Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
:
  • Hyperoxaluria
  • Nephrolithiasis

: 2014-11-10
: Drug: ALLN-177 ALLN-177 is orally administered oxalate decarboxylase (OxDc). The goal of oral therapy wi
Completed : A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
:
  • Secondary Hyperoxaluria
  • Nephrolithiasis
  • Secondary Hyperoxaluria
  • Nephrolithiasis
  • Drug: ALLN-177 ALLN-177 7,500

Not yet recruiting : Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients
: Oxalate, Primary Hyperoxaluria, Microbiome
: 2016-05-25
Completed : Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones
:
  • Secondary Hyperoxaluria
  • Nephrolithiasis
  • Drug: ALLN-177 low dose ALLN-1
<<< Previous | Next >>>